1. High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia
   Lin Fu et al, 2017, Cancer Sci CrossRef
2. Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and Sézary syndrome
   Minami Sakamoto et al, 2017, J Dermatol CrossRef
3. miR-125bpromotesMLL-AF9–driven murine acute myeloid leukemia involving aVEGFA-mediated non–cell-intrinsic mechanism
   Jun Liu et al, 2017, Blood CrossRef
4. Identification of specifically activated angiogenic molecules in HMGB-1-induced angiogenesis
   Won Kyu Kim et al, 2017, BMB Rep. CrossRef
5. Profiling of microRNAs in AML cells following overexpression or silencing of the VEGF gene
   Li Li et al, 2017 CrossRef
6. Levels of bone marrow microvessel density are crucial for evaluating the status of acute myeloid leukemia
   YANQIU SONG et al, 2015 CrossRef
7. A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
   , 2017, IJMS CrossRef
8. Response of Myeloid Leukemia Cells to Luteolin is Modulated by Differentially Expressed Pituitary Tumor-Transforming Gene 1 (PTTG1) Oncoprotein
   Pei-Yi Chen et al, 2018, IJMS CrossRef
9. Synthesis, Characterization and Cytotoxicity Studies of 1, 2, 3-triazoles and 1, 2, 4-triazolo [1, 5-a] pyrimidines in Human Breast Cancer Cells
   Maryam Gilandoust et al, 2018, Bioorganic & Medicinal Chemistry Letters CrossRef
10. Targeting VEGF/VEGFRs Pathway in the Antiangiogenic Treatment of Human Cancers by Traditional Chinese Medicine
    Cheng Zhang et al, 2018, Integr Cancer Ther CrossRef
11. CROSSTALK BETWEEN BCR-ABL AND PROTEASE-ACTIVATED RECEPTOR 1 (PAR1) SUGGESTS A NOVEL TARGET IN CHRONIC MYELOID LEUKEMIA
    Camilla de S. Borges et al, 2018, Experimental Hematology CrossRef
12. Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair
    Zhiwei Zhang et al, 2016, J Am Heart Assoc CrossRef
13. Thiazole in the targeted anticancer drug discovery
    Adileh Ayati et al, 2019, Future Medicinal Chemistry CrossRef
14. Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma
    María E. Sarasquete et al, 2013, Br J Haematol CrossRef
15. Role of Plasma Membrane Caveolae/Lipid Rafts in VEGF-Induced Redox Signaling in Human Leukemia Cells
    Cristiana Caliceti et al, 2014, BioMed Research International CrossRef
16. Gene expression profiling for targeted cancer treatment
    Anton Yuryev, 2015, Expert Opinion on Drug Discovery CrossRef
17. Development of a robust reporter-based assay for the bioactivity determination of anti-VEGF therapeutic antibodies
    Lan Wang et al, 2016, Journal of Pharmaceutical and Biomedical Analysis CrossRef
18. Perturbed Calcineurin-NFAT Signaling Is Associated with the Development of Alzheimer’s Disease
    Masashi Asai et al, 2016, Biological & Pharmaceutical Bulletin CrossRef
19. Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications
    Rosangela Invernizzi et al, 2017, Leukemia & Lymphoma CrossRef
20. N-Ethyl-n-Nitrosourea Induced Leukaemia in a Mouse Model through Upregulation of Vascular Endothelial Growth Factor and Evading Apoptosis
    Abdullahi Aliyu et al, 2020, Cancers CrossRef
21. Avian leukosis virus subgroup J induces VEGF expression via NF-κB/PI3K-dependent IL-6 production
    Yanni Gao et al, 2016, Oncotarget CrossRef
22. Synergistic Anti Leukemia Effect of a Novel Hsp90 and a Pan Cyclin Dependent Kinase Inhibitors
    Ashraf N. Abdalla et al, 2020, Molecules CrossRef
23. Modulation of cytokine production by monocytes and developing‐dendritic cells under the influence of leukemia and lymphoma cell products
    Juliana Maria Motta et al, 2020, Cell Biol Int CrossRef
24. Identification of MiR-93-5p Targeted Pathogenic Markers in Acute Myeloid Leukemia through Integrative Bioinformatics Analysis and Clinical Validation
    Jie Wang et al, 2021, Journal of Oncology CrossRef
25. Gastrointestinal Toxicities of Targeted Therapy
    Tahmida Chowdhury et al, 2020 CrossRef
26. Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy
    Benedetta Apollonio et al, 2021, Front. Oncol. CrossRef
27. The Tyrosine Kinase-Driven Networks of Novel Long Non-coding RNAs and Their Molecular Targets in Myeloproliferative Neoplasms
    Nonthaphat Kent Wong et al, 2021, Front. Cell Dev. Biol. CrossRef
28. Targeting metabolism: A potential strategy for hematological cancer therapy
    Xue Tang et al, 2022, WJCC CrossRef
29. CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation
    Daniel Hwang et al, 2022, Proc. Natl. Acad. Sci. U.S.A. CrossRef
30. The effect of novel synthetic semicarbazone- and thiosemicarbazone-linked 1,2,3-triazoles on the apoptotic markers, VEGFR-2, and cell cycle of myeloid leukemia
    Esraa M. Othman et al, 2022, Bioorganic Chemistry CrossRef
31. Apoptotic and Cell Cycle Effects of Triterpenes Isolated from Phoradendron wattii on Leukemia Cell Lines
    Lía S. Valencia-Chan et al, 2022, Molecules CrossRef
32. Lupane Triterpene Derivatives Improve Antiproliferative Effect on Leukemia Cells through Apoptosis Induction
    Lía S. Valencia-Chan et al, 2022, Molecules CrossRef
33. Synthesis and Molecular Docking of Some Novel 3-Thiazolyl-Coumarins as Inhibitors of VEGFR-2 Kinase
    Tariq Z. Abolibda et al, 2023, Molecules CrossRef
34. Comprehensive analysis of the oncogenic roles of vascular endothelial growth factors and their receptors in stomach adenocarcinoma
    Jianxin Li et al, 2023, Heliyon CrossRef
35. Molecular Targeting Therapy for Advanced Gastric Carcinoma
    纪震 王, 2023, ACM CrossRef
36. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways
    Maryam Bakhtiyari et al, 2023, Cell Commun Signal CrossRef
37. Novel circular RNAs of the apoptosis‐related BAX and BCL2L12 genes identified in a chronic lymphocytic leukemia cell line using nanopore sequencing
    Christos K. Kontos et al, 2023, FEBS Open Bio CrossRef
38. Pre-operative plasma VEGF-C levels portend recurrence in epithelial ovarian cancer patients and is a bankable prognostic marker even in the initial assessment of a patient
    J. Bhaskari et al, 2024, J Ovarian Res CrossRef
39. The Depth of the Molecular Response in Patients with Chronic Myeloid Leukemia Correlates with Changes in Humoral Immunity
    Michał Janowski et al, 2024, JCM CrossRef
40. Recent Advances and Future Directions on Small Molecule VEGFR Inhibitors in Oncological Conditions
    Amandeep Thakur et al, 2024, European Journal of Medicinal Chemistry CrossRef
41. Synthesis, Radiolabeling, and Biodistribution Study of a Novel DOTA-Peptide for Targeting Vascular Endothelial Growth Factor Receptors in the Molecular Imaging of Breast Cancer
    Fatemeh Ebrahimi et al, 2024, Pharmaceutics CrossRef
42. 1,3-Disubstituted Thiourea Derivatives: Promising Candidates for Medicinal Applications with Enhanced Cytotoxic Effects on Cancer Cells
    Paulina Strzyga-Łach et al, 2024, European Journal of Pharmacology CrossRef
43. Expanding Beyond Genetic Subtypes in B-Cell Acute Lymphoblastic Leukemia: A Pathway-Based Stratification of Patients for Precision Oncology
    Ozlem Ulucan, 2024, OMICS: A Journal of Integrative Biology CrossRef